Clinical trials
Prostatic Neoplasms, Castration-Resistant trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2023 | 4 |
| 2024 | 4 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 9 |
| Completed | 4 |
| Active, not recruiting | 3 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen Research & Development, LLC | 5 |
| MacroGenics | 3 |
| Cancer Research UK | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Astellas Pharma Global Development, Inc. | 1 |
| Boehringer Ingelheim | 1 |
| Celcuity Inc | 1 |
| Hoffmann-La Roche | 1 |
| Novartis Pharmaceuticals | 1 |
| Sheffield Teaching Hospitals NHS Foundation Trust | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms, Castration-Resistant | 18 |
| Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Endometrial Neoplasms | 3 |
| Melanoma | 3 |
| Pancreatic Neoplasms | 3 |
| Prostatic Neoplasms | 3 |
| Stomach Neoplasms | 3 |
| Urinary Bladder Neoplasms | 3 |
| Uterine Cervical Neoplasms | 3 |
Trials
Showing 76 to 18 of 18. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.